Brief: Acrux Says Co And Amring Pharmaceuticals Mutually Agreed To Terminate Agreement
15/12/2022 01:39
Dec 15 (Reuters) - Acrux Ltd ACR.AX :
* CO AND AMRING PHARMACEUTICALS INC. MUTUALLY AGREED TO
TERMINATE
AGREEMENT FOR COMMERCIALISATION OF GENERIC TOPICAL PRODUCT IN US
* RETAINS EXCLUSIVE OWNERSHIP OF ALL RIGHTS AND INTELLECTUAL
PROPERTY ASSOCIATED WITH PRODUCT
Source text for Eikon: ID:nASX23Hkb9
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share